<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/agency/National_Institutes_of_Health/2006-12-28/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Tue, Dec 2 2008 11:00:00 GMT</pubDate>
    <lastBuildDate>Tue, Dec 2 2008 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  National Cancer Institute; Notice of Meeting ]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-28-06-9884</link>
  <description><![CDATA[
</p><p>    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute Director's Consumer Liaison Group.
</p><p>    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in  advance of the meeting.</p><p>    Name of Committee: National Cancer Institute Director's Consumer  Liaison Group.<br/> </p><p>    Date: January 25, 2007.<br/> </p><p>    Time: 1 p.m. 2:30 p.m.</p><p>    Agenda: (1) Approval Minutes of September 28, 2006 Teleconference 
and October 25, 2006 inperson meeting; (2) Introduce new Office of 
Advocacy Relations leadership and Director's charge to the DCLG members 
(3) Report of DCLG Member Activities; (4) Preparation for the March in
person meeting; (5) Public Comment Public Comment; (6) Action Items and  Conclusion.<br/>
[[Page 7<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-28-06-9884</guid>
  <pubDate>Thu, Dec 28 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  National Cancer Institute, Amended Notice of Meeting ]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-28-06-9888</link>
  <description><![CDATA[
</p><p>    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel, February 13, 2007, 8:00 a.m. 
to February 15, 2007, 5 p.m., Hyatt Regency bethesda, One Bethesda 
Metro Center, 7400 Wisconsin Avenue, Bethesda, MD, 20814 which was 
published in the Federal Register on November 30, 2006, 71 FR 69211.
</p><p>    The meeting notice is changed to reflect the name of the committee 
from ``SPORE II'' to ``SPORE in Prostate, Breast and Skin Cancer.'' The  meeting is closed to the public.<br/> </p><p>    Dated: December 20, 2006.<br/> Anna Snouffer,<br/>
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 069888 Filed 122806; 8:45 am]<br/>
BILLING CODE 414001M
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-28-06-9888</guid>
  <pubDate>Thu, Dec 28 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  National Institutes of Child Health and Human Development; Notice  of Closed Meeting]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-28-06-9889</link>
  <description><![CDATA[
</p><p>    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following  meetings.</p><p>    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
</p><p>    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Mentored Research Scientist  Development Award.<br/> </p><p>    Date: January 5, 2007.<br/> </p><p>    Time: 2 p.m. to 4 p.m.</p><p>    Agenda: To review and evaluate grant applications.
</p><p>    Place: National Institutes of Health, 6100 Executive Boulevard,  Rockville, MD 20852 (Telephone Conference Call).</p><p>    Con<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-28-06-9889</guid>
  <pubDate>Thu, Dec 28 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Center for Scientific Review; Notice of Closed Meeting ]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-28-06-9887</link>
  <description><![CDATA[
</p><p>    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following  meetings.</p><p>    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
</p><p>    Name of Committee: Center for Scientific Review Special Emphasis  Panel, Drug Discovery.<br/> </p><p>    Date: January 3, 2007.<br/> </p><p>    Time: 3 p.m. to 6 p.m.</p><p>    Agenda: To review and evaluate grant applications.
</p><p>    Place: National Institutes of Health, 6701 Rockledge Drive,  Bethesda, MD 20892 (Telephone Conference Call).</p><p>    Contact Person: Mary Custer, PhD., Scientific Review Administrator, <script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-28-06-9887</guid>
  <pubDate>Thu, Dec 28 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Prospective Grant of Exclusive License: Convection Enhanced  Delivery and Tracking of Gadolinium Conjugated]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-28-E6-22187</link>
  <description><![CDATA[ This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), 
Department of Health and Human Services, is contemplating the grant of 
an exclusive worldwide license to practice the invention embodied in: 
HHS. Ref. No. E2022002 ``Method for Convection Enhanced Delivery of 
Therapeutic Agents,'' Provisional Patent Application, 60/413,673; 
International Patent Application PCT/US03/30155, U.S. Patent 
Application Serial No. 10/528,310; European Patent Application Serial 
No. 03756863.1; Australian Patent Application No. 2003299140; Canadian 
Patent Application No. 2,499,573; and HHS Ref. No. E2062000/0 and /1 
``Method for Increasing the Distribution of Therapeutic Agents;'' and 
``Method for Increasing the Distribution of Nucleic Acids;'' 
Provisional Patent Application 60/250,286; Provisional Patent 
Application No. 60/286,308; U.S. Patent Application No. 09/999,203; 
U.S. Patent Application No. 10/132,681; and Canadian Patent Application 
N<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-28-E6-22187</guid>
  <pubDate>Thu, Dec 28 2006 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

